Braester A, Quitt M
Lin Medical Center, Hematology Clinic, Kupat Holim Clalit, Haifa, Israel.
Acta Haematol. 2000;104(1):50-1. doi: 10.1159/000041071.
We report on a patient with essential thrombocythemia treated with hydroxyurea who became febrile 3 weeks after the treatment was started. After drug withdrawal, the fever resolved but after rechallenge there was recurrence of the fever. Although hydroxyurea-induced fever is rare, this drug must be added to the list of drugs that produce fever and the physicians should be aware of this possibility.